Shi Y - Search Results

1

Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.

Xue C, Wei W, Sun P, Zheng W, Diao X, Xu F, Huang J, An X, Xia W, Hong R, Jiang K, Huang R, Yuan Z, Wang S, Li A, Zou R, Shi Y. Xue C, et al. Among authors: shi y. Breast Cancer Res Treat. 2019 Feb;173(3):619-628. doi: 10.1007/s10549-018-4997-2. Epub 2018 Nov 3. Breast Cancer Res Treat. 2019. PMID: 30392113

2

[Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].

Peng RJ, Dong QM, Shi YX, Cao Y, Zhou ZM, Yuan ZY, Li S, Li H, Jiang WQ. Peng RJ, et al. Among authors: shi yx. Ai Zheng. 2006 Aug;25(8):1039-43. Ai Zheng. 2006. PMID: 16965690 Chinese.

3

[Efficacy of docetaxel combined capecitabine on metastatic breast cancer].

Wang XX, Zhou ZM, Yuan ZY, Zhang DS, Shi YX, Jiang WQ. Wang XX, et al. Ai Zheng. 2007 Apr;26(4):407-10. Ai Zheng. 2007. PMID: 17430662 Free article. Clinical Trial. Chinese.

4

[Retrospective analysis of 98 cases of breast cancer with liver metastasis].

Zhu MQ, Zhang DS, Su ZY, Shi YX, Peng RJ, Zhou NN, Liu DG, Jiang WQ. Zhu MQ, et al. Ai Zheng. 2007 Apr;26(4):423-6. Ai Zheng. 2007. PMID: 17430666 Free article. Chinese.

5

The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib.

Zhao YY, Li S, Zhang Y, Zhao HY, Liao H, Guo Y, Shi YX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Among authors: shi yx. Med Oncol. 2011 Sep;28(3):697-702. doi: 10.1007/s12032-010-9541-0. Epub 2010 May 11. Med Oncol. 2011. PMID: 20458561 Clinical Trial.

6

Expression and clinical significance of androgen receptor in triple negative breast cancer.

Luo X, Shi YX, Li ZM, Jiang WQ. Luo X, et al. Chin J Cancer. 2010 Jun;29(6):585-90. doi: 10.5732/cjc.009.10673. Chin J Cancer. 2010. PMID: 20507730 Free article.

7

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ, He YJ, Xu RH, Jiang WQ. An X, et al. Biomarkers. 2010 Sep;15(6):516-22. doi: 10.3109/1354750X.2010.491557. Biomarkers. 2010. PMID: 20602543

8

EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray.

Liu D, He J, Yuan Z, Wang S, Peng R, Shi Y, Teng X, Qin T. Liu D, et al. Among authors: shi y. Med Oncol. 2012 Jun;29(2):401-5. doi: 10.1007/s12032-011-9827-x. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264531

9

Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer.

Shi YX, Tan YT, Yuan ZY, Wang SS, Peng RJ, An X, Cao Y, Jin Y, Cai XY, Sun YL, Teng XY, Liu DG. Shi YX, et al. Med Oncol. 2012 Mar;29(1):39-47. doi: 10.1007/s12032-010-9798-3. Epub 2011 Feb 8. Med Oncol. 2012. PMID: 21302001

10

Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.

Wang S, Shi Y, Yuan Z, Wang X, Liu D, Peng R, Teng X, Qin T, Peng J, Lin G, Jiang X. Wang S, et al. Among authors: shi y. Med Oncol. 2012 Jun;29(2):547-53. doi: 10.1007/s12032-011-9964-2. Epub 2011 Apr 29. Med Oncol. 2012. PMID: 21528408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,657 results

Search Page

Filters